The $37bn Bill & Melinda Gates Foundation, the world’s largest philanthropic organisation, reportedly plans to take equity stakes in up to a dozen biotech companies this year in a quasi-corporate venturing model, following moves by peers including Wellcome Trust and Novo.

Trevor Mundel, the Gates Foundation’s recently appointed head of global health, told news provider Financial Times (FT) he hoped to oversee a series of investments in companies each likely to be worth several million dollars.

The Gates Foundation gives…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?